Publication details
The manifestation of oral mucositis in COVID-19 patients: A case-series
| Authors | |
|---|---|
| Year of publication | 2020 |
| Type | Article in Periodical |
| Magazine / Source | Dermatologic Therapy |
| MU Faculty or unit | |
| Citation | |
| Web | https://onlinelibrary.wiley.com/doi/10.1111/dth.14479 |
| Doi | http://dx.doi.org/10.1111/dth.14479 |
| Keywords | Oral Mucositis; COVID-19 |
| Description | We have read with great interest the correspondence of Kahraman et al (2020) on the emergence of oral mucosal changes adjacent to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; hereby we demonstrate the characteristics of 13 laboratoryconfirmed coronavirus disease (COVID-19) patients with oral mucositis according to the CARE guidelines. The referenced patients sought care at our department from April to August 2020 due to generalized pain and soreness within the oral cavity related mainly to nonkeratinized mucosa without a specific cause (Table 1). All included patients had previously undergone polymerase chain reaction (PCR) testing for SARS-CoV-2, which confirmed their infection with a mean cycle threshold (Ct) value of 18.46 ± 3.8 (12-26). Their mean age was 51.08 ± 8.79 (34-62) years old, and eight of them (62.5%) were females. Regarding their COVID-19 symptoms, two patients (15.4%) had persistent fever, four (30.8%) had ageusia, and two (15.4%) had anosmia. The majority of them (69.2%) had a mild course of SARS-CoV-2 infection and were prescribed paracetamol (PCM); contrarily, four patients experienced a moderate course of infection—two patients (15.4%) were prescribed chloroquine and other two (15.4%) were prescribed dexamethasone. |